Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Limbus-derived Stem Cells for Prevention of Postoperative Corneal Haze

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03295292
Recruitment Status : Recruiting
First Posted : September 27, 2017
Last Update Posted : February 26, 2019
Sponsor:
Information provided by (Responsible Party):
Vivek Singh, L.V. Prasad Eye Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2019
  Estimated Study Completion Date : June 2020
Publications of Results:
Basu S, Damala M, Singh V. Limbal Stromal Stem Cell Therapy for Acute and Chronic Superficial Corneal Pathologies: Early Clinical Outcomes of The Funderburgh Technique. Investigative Ophthalmology & Visual Science. 2017 Jun 23;58(8):3371-337